15th week of 2022 patent applcation highlights part 8 |
Patent application number | Title | Published |
20220110939 | ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS | 2022-04-14 |
20220110940 | COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING WITH EGFR INHIBITORS | 2022-04-14 |
20220110941 | COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS | 2022-04-14 |
20220110942 | GERM CELL NUCLEAR FACTOR LIGANDS AND METHODS OF USE THEREOF | 2022-04-14 |
20220110943 | TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS | 2022-04-14 |
20220110944 | FORMULATIONS OF LIXIVAPTAN FOR THE TREATMENT OF POLYCYSTIC DISEASE | 2022-04-14 |
20220110945 | CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS | 2022-04-14 |
20220110946 | METHODS FOR ADMINISTERING COMPOSITIONS COMPRISING HYDROXYTYROSOL AND BOSWELLIC ACID | 2022-04-14 |
20220110947 | CYPROTERONE ACETATE COMPOSITIONS AND USES THEREOF | 2022-04-14 |
20220110948 | COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF | 2022-04-14 |
20220110949 | A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF | 2022-04-14 |
20220110950 | 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2022-04-14 |
20220110951 | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR | 2022-04-14 |
20220110952 | THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS | 2022-04-14 |
20220110953 | METHODS AND COMPOSITIONS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CANCERS | 2022-04-14 |
20220110954 | COMPOUNDS, METHODS, AND TREATMENTS FOR ABNORMAL SIGNALING PATHWAYS FOR PRENATAL AND POSTNATAL DEVELOPMENT | 2022-04-14 |
20220110955 | DEUTERATED DERIVATIVES OF PSILOCYBIN AND USES THEREOF | 2022-04-14 |
20220110956 | DEUTERATED DERIVATIVES OF PSILOCYBIN AND USES THEREOF | 2022-04-14 |
20220110957 | PECTIN-ADRIAMYCIN CONJUGATE AS WELL AS PREPARATION METHOD AND USE THEREOF | 2022-04-14 |
20220110958 | LOW DOSE COMBINATION CDA SUBSTRATE DRUG/CEDAZURIDINE WITH EXTENDED ADMINISTRATION | 2022-04-14 |
20220110959 | Compositions and Methods for Reducing Oxidative Damage | 2022-04-14 |
20220110960 | ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | 2022-04-14 |
20220110961 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2022-04-14 |
20220110962 | ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF | 2022-04-14 |
20220110963 | REVERSE TRANSCRIPTASE BLOCKING AGENTS AND METHODS OF USING THE SAME | 2022-04-14 |
20220110964 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASES | 2022-04-14 |
20220110965 | METHODS AND MATERIALS FOR TREATING DIABETES OR LIVER STEATOSIS | 2022-04-14 |
20220110966 | POLYNUCLEOTIDES ENCODING VERY LONG-CHAIN ACYL-COA DEHYDROGENASE FOR THE TREATMENT OF VERY LONG-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY | 2022-04-14 |
20220110967 | METHODS AND COMPOSITIONS FOR THERAPEUTIC SKIN TREATMENTS IN DERMATOLOGICAL PROCEDURES AFFECTING SKIN'S BARRIER | 2022-04-14 |
20220110968 | COMPOSITIONS AND METHODS TO DISINFECT, TREAT AND PREVENT MICROBIAL INFECTIONS | 2022-04-14 |
20220110969 | Ready-To-Use Potassium Phosphates In Sodium Chloride Solutions | 2022-04-14 |
20220110970 | Engineered Extracellular Vesicle Delivery Systems and Uses Thereof | 2022-04-14 |
20220110971 | T Cell Modulator | 2022-04-14 |
20220110972 | APPARATUS AND METHOD FOR INACTIVATIVING VIRUSES AND PATHOGENS IN CONVALESCENT PLASMA UNITS FROM RECOVERED COVID-19 PATIENTS | 2022-04-14 |
20220110973 | METHOD AND COMPOSITION FOR TREATING TUMORS | 2022-04-14 |
20220110974 | GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY | 2022-04-14 |
20220110975 | METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS | 2022-04-14 |
20220110976 | T CELL RECEPTORS TARGETING PIK3CA MUTATIONS AND USES THEREOF | 2022-04-14 |
20220110977 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | 2022-04-14 |
20220110978 | METHODS AND COMPOSITIONS TO FACILITATE REPAIR OF AVASCULAR TISSUE | 2022-04-14 |
20220110979 | FIBROBLAST REGENERATIVE CELLS | 2022-04-14 |
20220110980 | PRIMED MUSCLE PROGENITOR CELLS AND USES THEREOF | 2022-04-14 |
20220110981 | COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA | 2022-04-14 |
20220110982 | MAPC TREATMENT OF BRAIN INJURIES AND DISEASES | 2022-04-14 |
20220110983 | METHODS OF PURIFYING AN ALLERGEN EXTRACT | 2022-04-14 |
20220110984 | Application of Dubosiella Newyorkensis in Prolonging Lifespan and Anti-Aging | 2022-04-14 |
20220110985 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE | 2022-04-14 |
20220110986 | STRAINS, COMPOSITION AND METHOD OF USE | 2022-04-14 |
20220110987 | MULTIPLE VIRAL ANTIGEN COVID VACCINE AND THERAPEUTIC | 2022-04-14 |
20220110988 | PSEUDORABIES VIRUS FOR TREATING TUMORS | 2022-04-14 |
20220110989 | Olive Oil Use | 2022-04-14 |
20220110990 | OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES | 2022-04-14 |
20220110991 | OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES | 2022-04-14 |
20220110992 | TOPICAL CROTON LECHLERI COMPOSITIONS AND THEIR USE IN THE TREATMENT OF A BACTERIAL COLONIZATION OR PRIMARY OR SECONDARY BACTERIAL INFECTION OF AN UNDERLYING SKIN DISORDER | 2022-04-14 |
20220110993 | COMPOSITIONS FOR TREATMENT OF JAW PAIN, TEMPOROMANDIBULAR JOINT AND MUSCLE DISORDER AND BRUXISM | 2022-04-14 |
20220110994 | COMPOSITION, FOOD SUPPLEMENT, COMPOSITION ACTING AS A FOOD SUPPLEMENT FOR CHILDREN, AND PRODUCTION METHOD | 2022-04-14 |
20220110995 | CARE COMPOSITION AND USE THEREOF | 2022-04-14 |
20220110996 | MOISTURIZING COMPOSITION | 2022-04-14 |
20220110997 | Combined Plant Extract For Getting Rid Of Mites And Acne And Preparation Method And Use Thereof | 2022-04-14 |
20220110998 | ESSENTIAL OIL EMULSION NOSTRIL TREATMENT COMPOSITION | 2022-04-14 |
20220110999 | METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2022-04-14 |
20220111000 | LISINOPRIL FORMULATIONS | 2022-04-14 |
20220111001 | Treatment of Constipation-Predominant Irritable Bowel Syndrome | 2022-04-14 |
20220111002 | TREATMENT OF SENSORINEURAL DEAFNESS | 2022-04-14 |
20220111003 | NEUROPROTECTIVE PEPTIDES | 2022-04-14 |
20220111004 | Combinatorial Apparatus for Disease Management | 2022-04-14 |
20220111005 | COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS | 2022-04-14 |
20220111006 | Modulation of Heparin-Binding Epidermal Growth Factor Activity for Tympanic Membrane Healing | 2022-04-14 |
20220111007 | Application of FGF21 in preparation of medicine for treating colorectal cancer | 2022-04-14 |
20220111008 | USE OF IL-15 PROTEIN COMPLEX JOINT PD-L1 ANTIBODY FOR TREATING TUMOR DISEASES | 2022-04-14 |
20220111009 | EXOGENOUS PROTEIN-EXPRESSING MICROORGANISM AND USE THEREOF | 2022-04-14 |
20220111010 | LONG-ACTING GLP-1R AGONIST AS A THERAPY OF NEUROLOGICAL AND NEURODEGENERATIVE CONDITIONS | 2022-04-14 |
20220111011 | Method and Compounds for Treating Diabetes and Associated Metabolic Diseases | 2022-04-14 |
20220111012 | METHODS OF PROMOTING REMYELINATION | 2022-04-14 |
20220111013 | COMPOUND DECREASING THE CONCENTRATION OF 2-HYDROXY-GLUTARATE | 2022-04-14 |
20220111014 | NOVEL GLUCOSE OXIDASE COMPOSITIONS | 2022-04-14 |
20220111015 | TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS | 2022-04-14 |
20220111016 | PEPTIDES WITH ANTI-TUMOR ACTIVITY | 2022-04-14 |
20220111017 | IMMUNOMODULATORY COMPOSITIONS AND METHODS | 2022-04-14 |
20220111018 | COMPOSITIONS AND METHODS FOR INHIBITING YEAST INFECTIONS | 2022-04-14 |
20220111019 | BRCA1 MODULATING COMPOUNDS, FORMULATIONS THEREOF, AND USES THEREOF | 2022-04-14 |
20220111020 | HEMOSTATIC COMPOSITIONS AND METHODS OF MAKING THEREOF | 2022-04-14 |
20220111021 | USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN | 2022-04-14 |
20220111022 | AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2022-04-14 |
20220111023 | NEOEPITOPE RNA CANCER VACCINE | 2022-04-14 |
20220111024 | VACCINE | 2022-04-14 |
20220111025 | VACCINE | 2022-04-14 |
20220111026 | CANCER VACCINES TARGETING MUC16 AND USES THEREOF | 2022-04-14 |
20220111027 | GLYCO-ENGINEERED IMMUNIZATION ANTIGENS | 2022-04-14 |
20220111028 | Combination Of A STING Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist | 2022-04-14 |
20220111029 | POLYMERIC NANOVACCINES AND USES THEREOF | 2022-04-14 |
20220111030 | ANTIGEN SPECIFIC MULTI EPITOPE-BASED ANTI-INFECTIVE VACCINES | 2022-04-14 |
20220111031 | Vaccines targeting M. catharrhalis | 2022-04-14 |
20220111032 | IMMUNOGENIC COMPOSITION FOR PORCINE EPIDEMIC DIARRHEA VIRUS | 2022-04-14 |
20220111033 | Methods and Compositions for Heterologous repRNA Immunizations | 2022-04-14 |
20220111034 | VIRUS COMPOSITIONS | 2022-04-14 |
20220111035 | RSV F/G CHIMERIC VACCINE | 2022-04-14 |
20220111036 | METHOD FOR DEFINING A PERSONALIZED VACCINE AGAINST HIV/AIDS | 2022-04-14 |
20220111037 | SARS-COV-2 VACCINES | 2022-04-14 |
20220111038 | COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, AND METHODS OF USING THE SAME | 2022-04-14 |